It one last attempt to put this to rest, I will hold your hand and give you some examples. Somehow, I doubt you will keep your word as you dont appear to have anything else to bring to this board.
Anyway...here are two examples...
1. Bioject Medical Technologies Inc. (NASDAQ:BJCT), a leading developer of needle-free injection therapy systems, today announced that holders of $615,000 of notes issued by the Company in November 2007 elected to convert their notes into Series F Convertible Preferred Stock at a significant price premium. The Company entered into a purchase agreement with these note holders pursuant to which it issued an aggregate of 8,314 shares of Series F Convertible Preferred Stock at $75.00 a share, with each preferred share convertible into 100 shares of common stock at $0.75 per share. Gross proceeds from the sale were $623,550, paid by cancellation of the outstanding principal amount of, and accrued interest on, the promissory notes. This is well over a 70% price premium to the market price on January 22, 2008. The converting note holders included two members of the Board, the President and Chief Executive Officer, who is also a board member, and two executive officers.
2. GRSR.PK ...An agreement was entered into between Peter Klamka (a Company Officer) and the Dutch Entity, which effectively transferred the title to a note held by Mr. Klamka to the Dutch Entity and the Dutch Entity agreed to make certain specified payments to Mr. Klamka at certain specified times. The transferred note of $466,665 was bearing 21% interest per annum and was convertible into common stock at $0.02 per share.
..........
Are you done yet?
Apology not required. Just do us both a favour and move on...
Just my opinion...
